BACKGROUND: Cryoballoon ablation for treatment of atrial fibrillation (AF) reduces procedure times, but limited data is available about its impact on electrophysiology (EP) lab efficiency in Central and Eastern Europe (CEE). Using CEE-specific procedure data, the present study modeled cryoballoon ablation procedures on EP lab resource consumption to improve efficiency. METHODS: A discrete event simulation model was developed to assess EP efficiency with cryoballoon ablation. Model inputs were taken from CEE sites within the Cryo Global Registry, namely Czech Republic, Hungary, Poland, Serbia, and Slovakia. The main endpoints were percentage of days that resulted in overtime and percentage of days with time for one extra simple EP procedure. Use of the 'figure of 8' (Fo8) closure technique to reduce procedure time was also examined. RESULTS: The mean lab occupancy time across all CEE sites was 133 ± 47 minutes (min: 104 minutes, max:181 minutes). Cryoballoon ablation in the base-case scenario resulted in 14.6% of days with overtime and 64.8% of days with time for an extra simple EP procedure. Use of the Fo8 closure technique enhanced these values to 5.5% and 85.3%, respectively. Model endpoints were most sensitive to changes in lab occupancy times and overtime start time. CONCLUSIONS: In this CEE-specific analysis of EP lab efficiency it was found that 3 cryoballoon ablation procedures could be performed in 1 lab day, leaving time for a 4th simple EP procedure on most days. As such, use cryoballoon ablation for PVI is an effective way to improve EP lab efficiency.

Clinical Provincial Hospital No 2 Rzeszow Poland

Department of Anatomy Jagiellonian University Medical College Kraków Poland

Faculty of Medicine University of Debrecen Debrecen Hungary

Gottsegen György Országos Kardiovaszkuláris Intézet Budapest Hungary

Institute for Cardiovascular Diseases Dedinje Belgrade Serbia

Medical University of Łódź Central University Hospital Łódź Poland

Medtronic United States

Na Homolce Hospital Prague Czech Republic

Národný ústav srdcových a cievnych chorôb Bratislava Slovakia

Stredoslovenský ústav srdcových a cievnych chorôb Banská Bystrica Slovakia

Východoslovenský ústav srdcovych a cievnych chorôb Košice Slovakia

See more in PubMed

Williams BA, Honushefsky AM, Berger PB. Temporal Trends in the Incidence, Prevalence, and Survival of Patients With Atrial Fibrillation From 2004 to 2016. Am J Cardiol. 2017;120(11):1961–1965. doi: 10.1016/j.amjcard.2017.08.014. PubMed DOI

Hosseini SM, Rozen G, Saleh A, et al. In-Hospital Complications, 2000 to 2013. JACC Clin Electrophysiol. 2017;3(11):1240–1248. doi: 10.1016/j.jacep.2017.05.005. PubMed DOI

Kirchhof P, Benussi S, Kotecha D, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. doi: 10.1093/eurheartj/ehw210. PubMed DOI

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2021;42(40):4194–4194. doi: 10.1093/eurheartj/ehab648. PubMed DOI

Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–666. doi: 10.1056/NEJM199809033391003. PubMed DOI

Metzner A, Kuck KH, Chun JKR. What we have learned: is pulmonary vein isolation still the cornerstone of atrial fibrillation ablation? Europace. 2022;24(Suppl 2):ii8–iiii13. doi: 10.1093/europace/euab268. PubMed DOI

Andrade JG, Wazni OM, Kuniss M, et al. Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(9):914–930. doi: 10.1016/j.jacc.2021.06.038. PubMed DOI

Boveda S, Metzner A, Nguyen DQ, et al. Single-Procedure Outcomes and Quality-of-Life Improvement 12 Months Post-Cryoballoon Ablation in Persistent Atrial Fibrillation: Results From the Multicenter CRYO4PERSISTENT AF Trial. JACC Clin Electrophysiol. 2018;4(11):1440–1447. doi: 10.1016/j.jacep.2018.07.007. PubMed DOI

Chun KR, Okumura K, Scazzuso F, et al. Cryo Global Registry Investigators. Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real-world global setting: Results from the Cryo AF Global Registry. J Arrhythm. 2021;37(2):356–367. doi: 10.1002/joa3.12504. PubMed DOI PMC

Su WW, Reddy VY, Bhasin K, et al. STOP Persistent AF Investigators. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial. Heart Rhythm. 2020;17(11):1841–1847. doi: 10.1016/j.hrthm.2020.06.020. PubMed DOI

DeVille JB, Svinarich JT, Dan D, et al. Comparison of resource utilization of pulmonary vein isolation: cryoablation versus RF ablation with three-dimensional mapping in the Value PVI Study. J Invasive Cardiol. 2014;26(6):268–272. PubMed

Klein G, Lickfett L, Schreieck J, et al. FAST-PVI Study Group. Comparison of ‚anatomically designed’ and ‚point-by-point’ catheter ablations for human atrial fibrillation in terms of procedure timing and costs in German hospitals. Europace. 2015;17(7):1030–1037. doi: 10.1093/europace/euu386. PubMed DOI

Kowalski M, DeVille JB, Svinarich JT, et al. Using Discrete Event Simulation to Model the Economic Value of Shorter Procedure Times on EP Lab Efficiency in the VALUE PVI Study. J Invasive Cardiol. 2016;28(5):176–182. PubMed

Metzner A, Straube F, Tilz RR, et al. FREEZE Cohort Study Investigators. Electrophysiology lab efficiency comparison between cryoballoon and point-by-point radiofrequency ablation: a German sub-analysis of the FREEZE Cohort study. BMC Cardiovasc Disord. 2023;23(1):8. doi: 10.1186/s12872-022-03015-8. PubMed DOI PMC

Rordorf R, Scazzuso F, Chun KR, et al. Cryo AF Global Registry Investigators. Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry. J Am Heart Assoc. 2021;10(24):e021323. doi: 10.1161/JAHA.121.021323. PubMed DOI PMC

Földesi C, Misiková S, Ptaszyński P, et al. Safety of cryoballoon ablation for the treatment of atrial fibrillation: First European results from the cryo AF Global Registry. Pacing Clin Electrophysiol. 2021;44(5):883–894. doi: 10.1111/pace.14237. PubMed DOI

Kuck KH, Brugada J, Fürnkranz A, et al. FIRE AND ICE Investigators. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374(23):2235–2245. doi: 10.1056/NEJMoa1602014. PubMed DOI

Packer DL, Kowal RC, Wheelan KR, et al. STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–1723. doi: 10.1016/j.jacc.2012.11.064. PubMed DOI

Laker LF, Froehle CM, Lindsell CJ, et al. The flex track: flexible partitioning between low- and high-acuity areas of an emergency department. Ann Emerg Med. 2014;64(6):591–603. doi: 10.1016/j.annemergmed.2014.05.031. PubMed DOI PMC

Caro JJ, Ward A, Deniz HB, et al. Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone. Value Health. 2007;10(1):13–22. doi: 10.1111/j.1524-4733.2006.00140.x. PubMed DOI

Velagic V, Mugnai G, Pasara V, et al. Use of figure of eight suture for groin closure with no heparin reversal in patients undergoing cryoballoon ablation for atrial fibrillation. J Interv Card Electrophysiol. 2021;60(3):433–438. doi: 10.1007/s10840-020-00776-0. PubMed DOI

Aytemir K, Canpolat U, Yorgun H, et al. Usefulness of ‚figure-of-eight’ suture to achieve haemostasis after removal of 15-French calibre femoral venous sheath in patients undergoing cryoablation. Europace. 2016;18(10):1545–1550. doi: 10.1093/europace/euv375. PubMed DOI

Rizzi S, Pannone L, Monaco C, et al. First experience with a transseptal puncture using a novel transseptal crossing device with integrated dilator and needle. J Interv Card Electrophysiol. 2022;65(3):731–737. doi: 10.1007/s10840-022-01329-3. PubMed DOI

Yap SC, Bhagwandien RE, Szili-Torok T. Use of a novel integrated dilator-needle system in cryoballoon procedures: a zero-exchange approach. J Interv Card Electrophysiol. 2022;65(2):527–534. doi: 10.1007/s10840-022-01294-x. PubMed DOI PMC

Kowalski M, Su WW, Holbrook R, et al. STOPPersistent AF Investigators. Impact of Cryoballoon Ablation on Electrophysiology Lab Efficiency During the Treatment of Patients With Persistent Atrial Fibrillation: A Subanalysis of the STOP Persistent AF Study. J Invasive Cardiol. 2021;33(7):E522–E530. PubMed

Qeska D, Singh SM, Qiu F, et al. Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada. Europace. 2023;25(5) doi: 10.1093/europace/euad074. PubMed DOI PMC